Novo Nordisk's pre-market decline in US stocks narrowed to 20%, while Eli Lilly rose more than 10%

2024-12-20 19:12:55

Novo Nordisk's pre-market decline narrowed to 20%, after a sharp drop of nearly 30%, the largest single-day drop on record, due to the company's weight loss drug CagriSema trial results falling short of expectations. Eli Lilly's pre-market rise was more than 10%.

weight loss drug Novo Nordisk Lilly

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    South Korean Ministry of Foreign Affairs: U.S. Secretary of State Rubio and South Korean and Japanese diplomats agreed to strengthen cooperation in areas such as energy, shipbuilding, and supply chain security (including critical minerals and artificial intelligence).
                            2025-07-11

                                    A South Korean transport ministry spokesman said it was preparing to order all airlines operating Boeing (BA.N) aircraft to check fuel taps in accordance with a 2018 notice from the U.S. Federal Aviation Administration (FAA).
                            2025-07-14

                                    Market news: Apple (AAPL.O) plans to launch new MacBook Pro, iPhone 17E and iPad in early 2026.
                            2025-07-11

                                    Shanghai: The scale of the city's artificial intelligence industry exceeded 118 billion yuan in the first quarter of this year
                            2025-07-10

                                    Bitcoin rises by more than $1,000 in the short term
                            2025-07-14